DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma

International Journal of Gynecological Cancer

Volumn 19, Issue 6, 2009, Pages 1047-1051

  Karihtala, Peeter ^a   Soini, Ylermi ^a,b   Vaskivuo, Liisa ^a   Bloigu, Risto ^a   Puistola, Ulla ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

8 OHdG; Antioxidant enzymes; Ovarian cancer; Oxidative stress; Peroxiredoxins; Reactive oxygen species

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; HYDROXYL RADICAL; MONOCLONAL ANTIBODY; NITRIC OXIDE; PEROXIREDOXIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 3; PEROXIREDOXIN 4; PEROXIREDOXIN 5; PEROXIREDOXIN 6; POLYCLONAL ANTIBODY; RADICAL; REACTIVE OXYGEN METABOLITE; THIOREDOXIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CARCINOGENESIS; CELL NUCLEUS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYTOPLASM; DISEASE MARKER; DNA ADDUCT; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CARCINOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; UNDIFFERENTIATED CARCINOMA;

ANTIOXIDANTS; CARCINOMA; CELL NUCLEUS; CYTOPLASM; DNA ADDUCTS; FEMALE; GUANINE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; OVARIAN NEOPLASMS; OXIDATIVE STRESS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TYROSINE;

EID: 70349229317     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181ad0f0d     Document Type: Article

References (19)

1. Klaunig JE, Xu Y, Isenbergs JS, et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 1998;106: 289-295.
2. Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 2001;3:323-327.
3. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer. 1996;32:30-38.
4. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS. 2007;115:81-103.
5. Arner ES, Holmgren A. The thioredoxin system in cancer. Semin Cancer Biol. 2006;16:420-426.
6. Gromer S, Urig S, Becker K. The thioredoxin systemVfrom science to clinic. Med Res Rev. 2004;24:40-89.
7. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000;21:361-370.
8. Radi R, Rodriguez M, Castro L, et al. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys. 1994;308:89-95.
9. Tavassoéli FA, Devilee P. Tumours of the Breast and Female Genital Organs. IARC Press-WHO; 2003.
10. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res. 2004;567:1-61.
11. Shen J, Deininger P, Hunt JD, et al. 8-Hydroxy-2¶-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer. 2007;109:574-580.
12. Mitsumoto A, Takanezava Y, Okawa K, et al. Variants of peroxiredoxin expression in response to hydroperoxide stress. Free Radic Biol Med. 2001;30:625-635.
13. Bast A, Wolf G, Oberbaumer I, et al. Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia. 2002;45:867-876.
14. Lee W, Choi KS, Riddell J, et al. Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2. J Biol Chem. 2007;282:22011-22022.
15. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 2005;38:1543-1552.
16. Kinnula VL, Lehtonen S, Sormunen R, et al. Overexpression of peroxiredoxins I, II, III, Vand VI in malignant mesothelioma. J Pathol. 2002;196:316-323.
17. Karihtala P, Mäntyniemi A, Kang SW, et al. Peroxiredoxins in breast carcinoma. Clin Cancer Res. 2003;9:3418-3424.
18. Soini Y, Kallio JP, Hirvikoski P, et al. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma. APMIS. 2006;114:329-337.
19. Kim JH, Bogner PN, Ramnath N, et al. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin Cancer Res. 2007;13:3875-3882.